The TGFβ-induced lncRNA TBILA promotes non-small cell lung cancer progression in vitro and in vivo via cis-regulating HGAL and activating S100A7/JAB1 signaling.

Long non-coding RNAs (lncRNAs) play critical roles in multiple cellular processes in non-small cell lung cancer (NSCLC); however, the involvement of lncRNAs in the transforming growth factor-beta (TGFβ) signaling pathway, the critical tumor cell epithelial-mesenchymal transition (EMT) and metastasis pathway, remains poorly understood. To address this issue, we compared the lncRNAs expression patterns of NSCLC cells treated with and without TGFβ1 treatment. We observed that one of the most prominent hits, TGFβ-induced lncRNA (TBILA), promoted NSCLC progression and was upregulated in tumor tissues. Upregulated TBILA promotes human germinal center-associated lymphoma (HGAL) expression by binding to the Smad transcription factor complex, thereby enhancing RhoA activation. In addition, TBILA induces the S100A7-c-Jun activation domain-binding protein 1 (JAB1) pathway by binding to nuclear S100A7 and enhances pro-survival pathways in NSCLC. These findings have provided us with a new perspective regarding the regulation of the TGFβ signaling pathway in NSCLC and suggest that the lncRNA TBILA can serve as a target for anticancer therapies.

[1]  H. Aburatani,et al.  Transforming growth factor-β-induced lncRNA-Smad7 inhibits apoptosis of mouse breast cancer JygMC(A) cells , 2014, Cancer science.

[2]  David Padua,et al.  Roles of TGFβ in metastasis , 2009, Cell Research.

[3]  H. Moses,et al.  The roles of TGFβ in the tumour microenvironment , 2013, Nature Reviews Cancer.

[4]  Michael C. Ostrowski,et al.  RAGE mediates S100A7-induced breast cancer growth and metastasis by modulating the tumor microenvironment. , 2015, Cancer research.

[5]  C. Powell,et al.  Update in lung cancer and mesothelioma 2012. , 2013, American journal of respiratory and critical care medicine.

[6]  A. Peng,et al.  Selective expression of S100A7 in lung squamous cell carcinomas and large cell carcinomas but not in adenocarcinomas and small cell carcinomas , 2008, Thorax.

[7]  R. Kalluri.  The biology and function of fibroblasts in cancer , 2016, Nature Reviews Cancer.

[8]  Frank Grützner,et al.  The evolution of lncRNA repertoires and expression patterns in tetrapods , 2014, Nature.

[9]  J. Massagué,et al.  TGFβ in Cancer , 2008, Cell.

[10]  Xiaoqing Lu,et al.  HGAL, a germinal center specific protein, decreases lymphoma cell motility by modulation of the RhoA signaling pathway. , 2010, Blood.

[11]  Steven J. M. Jones,et al.  MEG3 long noncoding RNA regulates the TGF-β pathway genes through formation of RNA–DNA triplex structures , 2015, Nature Communications.

[12]  Zhihua Liu,et al.  S100A7 promotes the migration, invasion and metastasis of human cervical cancer cells through epithelial–mesenchymal transition , 2017, Oncotarget.

[13]  David J Weber,et al.  S100 proteins in cancer , 2015, Nature Reviews Cancer.

[14]  R. Donato,et al.  Functions of S100 proteins. , 2012, Current molecular medicine.

[15]  L. Staudt,et al.  Two newly characterized germinal center B-cell-associated genes, GCET1 and GCET2, have differential expression in normal and neoplastic B cells. , 2003, The American journal of pathology.

[16]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[17]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[18]  Howard Y. Chang,et al.  Long Noncoding RNAs in Cancer Pathways. , 2016, Cancer cell.

[19]  W. Jiang,et al.  The clinical significance of Psoriasin for non-small cell lung cancer patients and its biological impact on lung cancer cell functions , 2012, BMC Cancer.

[20]  Howard Y. Chang,et al.  Genome regulation by long noncoding RNAs. , 2012, Annual review of biochemistry.

[21]  Long non-coding RNA NKILA inhibits migration and invasion of non-small cell lung cancer via NF-κB/Snail pathway , 2017, Journal of experimental & clinical cancer research : CR.

[22]  L. Murphy,et al.  S100A7 and the progression of breast cancer , 2004, Breast Cancer Research.

[23]  Maite Huarte.  The emerging role of lncRNAs in cancer , 2015, Nature Medicine.

[24]  Stephen T. C. Wong,et al.  EMT is not required for lung metastasis but contributes to chemoresistance , 2016 .

[25]  I. Lossos,et al.  miR-155 regulates HGAL expression and increases lymphoma cell motility. , 2012, Blood.

[26]  A. Porter,et al.  Deregulation of Rho GTPases in cancer , 2016, Small GTPases.

[27]  Q. Song,et al.  Crosstalk between transforming growth factor-β signaling pathway and long non-coding RNAs in cancer. , 2016, Cancer letters.

[28]  Yu Fan,et al.  TGF-β–Induced Upregulation of malat1 Promotes Bladder Cancer Metastasis by Associating with suz12 , 2014, Clinical Cancer Research.

[29]  F. Liu,et al.  A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma. , 2014, Cancer cell.

[30]  Takaya Nagasaki,et al.  Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth , 2015, Cancers.

[31]  K. Shilo,et al.  S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways. , 2011, Cancer research.

[32]  Lingyun Huang,et al.  Identification and validation of S100A7 associated with lung squamous cell carcinoma metastasis to brain. , 2007, Lung cancer.

[33]  Robert Tibshirani,et al.  HGAL is a novel interleukin-4-inducible gene that strongly predicts survival in diffuse large B-cell lymphoma. , 2003, Blood.

[34]  Y. Zheng,et al.  Rho GTPases: Anti- or Pro-neoplastic Targets? , 2016, Oncogene.

[35]  L. Murphy,et al.  Psoriasin interacts with Jab1 and influences breast cancer progression. , 2003, Cancer research.

[36]  Junnian Zheng,et al.  The emerging roles of Jab1/CSN5 in cancer , 2016, Medical Oncology.

[37]  Pornpimol Charoentong,et al.  ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks , 2009, Bioinform..

[38]  Data production leads,et al.  An integrated encyclopedia of DNA elements in the human genome , 2012 .

[39]  A. Hata,et al.  Targeting the TGFβ signalling pathway in disease , 2012, Nature Reviews Drug Discovery.

[40]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[41]  Zheng Zhao,et al.  Identifying and functionally characterizing tissue-specific and ubiquitously expressed human lncRNAs , 2016, Oncotarget.

[42]  P. Jänne,et al.  TGF&bgr; pathway inhibition in the treatment of non‐small cell lung cancer , 2017, Pharmacology & therapeutics.

[43]  Xiang Du,et al.  Long non-coding RNAs in cancer invasion and metastasis , 2015, Modern Pathology.

[44]  L. Murphy,et al.  The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer. , 2005, Cancer research.

[45]  Yi Zheng,et al.  Approaches of targeting Rho GTPases in cancer drug discovery , 2015, Expert opinion on drug discovery.

[46]  H. Ford,et al.  Molecular Pathways Molecular Pathways : Targeting the TGF-b Pathway for Cancer Therapy , 2012 .

[47]  K. Rabe,et al.  Management of non-small-cell lung cancer: recent developments , 2013, The Lancet.

[48]  Yunbao Pan,et al.  Targeting Jab1/CSN5 in nasopharyngeal carcinoma. , 2012, Cancer letters.

[49]  Novel Insights into the Roles of Rho Kinase in Cancer , 2016, Archivum Immunologiae et Therapiae Experimentalis.